Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

49.64
Delayed Data
As of Dec 09
 +1.50 / +3.12%
Today’s Change
35.07
Today|||52-Week Range
54.96
+30.08%
Year-to-Date
Roche Presents Positive Follicular Lymphoma Data on Gazvya
Dec 06 / Zacks.com - Paid Partner Content
Cytori Scleroderma Study Two-Year Follow-Up Data Published
Nov 30 / Zacks.com - Paid Partner Content
Pfizer Leukemia Drug Meets Primary Endpoint in Phase III
Dec 06 / Zacks.com - Paid Partner Content
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Nov 30 / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec 06 / Zacks.com - Paid Partner Content
Foamix Completes Enrolment in Phase III Acne Drug Studies
Nov 30 / Zacks.com - Paid Partner Content
Alexion Presents Data from Ultra-Rare Blood Disorder Study
Dec 05 / Zacks.com - Paid Partner Content
Aimmune Closes Enrolment in Phase III Peanut Allergy Study
Nov 30 / Zacks.com - Paid Partner Content
3 Biotech Stocks to Buy in December
Dec 01 / MotleyFool.com - Paid Partner Content
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close48.14
Today’s open48.25
Day’s range47.36 - 49.70
Volume129,317
Average volume (3 months)108,372
Market cap$725.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)+6.47%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.93%
P/E ratio21.3
Price/Sales6.29
Price/Book3.54

Competitors

 Today’s
change
Today’s
% change
NVCRNovocure Ltd+0.30+3.43%
ANGOAngioDynamics Inc-0.07-0.41%
CSIICardiovascular Syste...-0.04-0.16%
ATRCAtriCure Inc+0.28+1.53%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts


Search for Jobs